India plans incentives for diabetes, obesity drug makers in 2026, government official says, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

“The (Indian) companies (planning) manufacturing GLP-1 drugs have applied for the government’s production-linked incentive (PLI) scheme,” Arunish Chawla, Secretary of Department of Pharmaceuticals, told Reuters., “The (Indian) companies (planning) manufacturing GLP-1 drugs have applied for the government’s production-linked incentive (PLI) scheme,” Arunish Chawla, Secretary of Department of Pharmaceuticals, told Reuters., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *